在CYP2C19表型之间评估胺素的耐受性和疗效
Alexis Koon1, Jiaxian He2, Jai Patel3
1Rosalind Franklin University of Medicine & Science, College of Pharmacy, North Chicago, IL 60064, USA.
Pharmacogenomics
|October 17, 2023
概括
这项研究没有发现CYP2C19遗传变异与导致在干细胞移植患者中停止静脉注射米丁治疗Pneumocystis jirovecii肺炎预防的副作用之间的联系.
科学领域:
- 药物遗传学 药物遗传学
- 造血干细胞移植 造血干细胞移植
- 传染病预防 传染病预防
背景情况:
- 静脉注射的胺是血液造血干细胞移植 (HSCT) 接受者的肺炎肺炎 (PJP) 的主要预防药物.
- 胺氨酸的代谢涉及CYP2C19,这是一个受显著药物遗传变异性的酶.
- 了解CYP2C19表型对胺素耐受性的影响对于优化HSCT患者的PJP预防至关重要.
研究的目的:
- 调查CYP2C19表型与因药物相关副作用而停止静脉注射胺之间的关联.
- 根据CYP2C19的药物遗传特征,评估异性HSCT患者中胺氨酸停药和PJP的发生率.
主要方法:
- 追溯分析了81名全基性高血压患者,这些患者在PJP预防中接受静脉注射胺.
- 将患者分为CYP2C19表型组的分类.
- 单变量逻辑回归分析,以评估CYP2C19表型与因副作用而停止服用胺之间的关联.
主要成果:
- 总共有10名患者 (12.3%) 因副作用而停止服用胺胺.
- 不同的CYP2C19表型组 (p=0.18) 之间没有观察到塔米丁中止率的统计学上显著差异.
- 同样,在CYP2C19表型和胺相关副作用的发生之间也没有发现显著的关联 (p=0.475).
结论:
- 该研究没有发现CYP2C19表型与由于HSCT接受者的副作用而停止静脉注射胺素之间的显著关联.
- 在这个队列中,药物停用和PJP感染率都很低,这表明胺预防的整体耐受性和有效性很好.
- 进一步的研究可能会探索其他因素,影响这种脆弱患者群体中胺素耐受性.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
167
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
167
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
209
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
209
Determination of Michaelis Constant and Maximum Elimination Rate
118
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
118
Renal Failure: Dose Adjustments
97
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
97
Hepatic Drug Excretion: Influencing Factors
134
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
134


